De Angelis V et al. |
Endocannabinoids control platelet activation and limit aggregate formation under flow. |
2014 |
PLoS ONE |
pmid:25264625
|
Özdemir B et al. |
Endocannabinoids and inflammatory response in periodontal ligament cells. |
2014 |
PLoS ONE |
pmid:25226300
|
Jia J et al. |
Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase. |
2014 |
Oxid Med Cell Longev |
pmid:25136404
|
Sexton M et al. |
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. |
2014 |
Inflammopharmacology |
pmid:25135301
|
Björklund E et al. |
Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study. |
2014 |
PLoS ONE |
pmid:25078278
|
Lau BK et al. |
Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. |
2014 |
Br. J. Pharmacol. |
pmid:25041240
|
Laprairie RB et al. |
Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons. |
2014 |
J. Biol. Chem. |
pmid:25037227
|
Navarria A et al. |
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. |
2014 |
Pharmacol. Res. |
pmid:24861565
|
Marichal-Cancino BA et al. |
Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats. |
2014 |
Basic Clin. Pharmacol. Toxicol. |
pmid:24118786
|
Abdulnour J et al. |
Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. |
2014 |
Obesity (Silver Spring) |
pmid:23616305
|
Alvheim AR et al. |
Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet. |
2014 |
Lipids |
pmid:24081493
|
Yang K et al. |
Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus. |
2014 |
Hippocampus |
pmid:25087967
|
Fezza F et al. |
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. |
2014 |
Mol. Cell. Neurosci. |
pmid:25064144
|
Jergas B et al. |
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24853577
|
Pava MJ et al. |
Endocannabinoid modulation of cortical up-states and NREM sleep. |
2014 |
PLoS ONE |
pmid:24520411
|
Sanson B et al. |
Crystallographic study of FABP5 as an intracellular endocannabinoid transporter. |
2014 |
Acta Crystallogr. D Biol. Crystallogr. |
pmid:24531463
|
Fowler CJ |
Has FLAT fallen flat? |
2014 |
Trends Pharmacol. Sci. |
pmid:24398120
|
Sousa-Valente J et al. |
Anandamide in primary sensory neurons: too much of a good thing? |
2014 |
Eur. J. Neurosci. |
pmid:24494681
|
Rea K et al. |
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state. |
2014 |
Eur. J. Neurosci. |
pmid:24494683
|
Alpár A et al. |
Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. |
2014 |
Nat Commun |
pmid:25030704
|